why conformis stock dropping

Full Answer

Who holds conformis'stock?

Only 3.01% of the stock of Conformis is held by insiders. 42.49% of the stock of Conformis is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Earnings for Conformis are expected to decrease in the coming year, from ($0.02) to ($0.23) per share.

How much of conformis's stock is owned by institutions?

42.49% of the stock of Conformis is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Earnings for Conformis are expected to decrease in the coming year, from ($0.02) to ($0.23) per share.

What are analysts'price targets for conformis's stock?

4 analysts have issued 1-year price targets for ConforMIS's shares. Their predictions range from $2.50 to $4.00. On average, they anticipate ConforMIS's share price to reach $3.13 in the next twelve months. This suggests a possible upside of 30.8% from the stock's current price.

What is CFMS stock worth now?

Since then, CFMS stock has increased by 16.8% and is now trading at $0.7710. View which stocks have been most impacted by COVID-19. Are investors shorting Conformis? Conformis saw a increase in short interest in the month of November.

Is Conformis stock a good buy?

Conformis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

What happened to Conformis?

Conformis, Inc. BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced that it was suspending all distribution operations to Russia and any Russian-based entities for its orthopedic medical devices.

When did Conformis go public?

Conformis began trading on The NASDAQ Global Select Market on July 1, 2015.

What is Conformis knee replacement?

Conformis knee replacements are designed to match every aspect of your natural knee. The goal of any knee replacement is to be pain-free, restore natural motion, and for patients to return to their everyday activities.

How Do You Calculate Return On Equity?

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

Why Is ROE Important For Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company’s earnings growth potential.

About Conformis

ConforMIS, Inc. is a medical technology company, which engages in the development, manufacture, and sale of joint replacement implants. It operates through the following geographical segments: United States; Germany; and Rest of the World. The firm's products include iUni, iDuo, iTotal CR, and iTotal.

Headlines

How Many Conformis, Inc. (NASDAQ:CFMS) Shares Do Institutions Own? - Nasdaq

Conformis (NASDAQ:CFMS) Frequently Asked Questions

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Conformis in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Conformis stock. View analyst ratings for Conformis or view top-rated stocks.

What's the opportunity in Conformis?

Good news, investors! Conformis is still a bargain right now according to my price multiple model, which compares the company's price-to-earnings ratio to the industry average. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows.

What kind of growth will Conformis generate?

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations.

What is Conformis' current short interest?

Short interest is the volume of Conformis shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 3,580,000 shares of CFMS short. 1.99% of Conformis' shares are currently sold short. Learn More on Conformis' current short interest.

What is a good short interest ratio for Conformis?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers.

Which institutional investors are shorting Conformis?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Conformis: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Conformis?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock.

Is Conformis' short interest increasing or decreasing?

Conformis saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 3,580,000 shares, an increase of 29.7% from the previous total of 2,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment.

What is Conformis' float size?

Conformis currently has issued a total of 186,100,000 shares. Some of Conformis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.80 billion), S&P Global Inc. ($7.56 billion), Charter Communications, Inc. ($5.90 billion), Palo Alto Networks, Inc. ($3.22 billion), Lucid Group Inc ($2.77 billion), Rivian ($2.70 billion), Wayfair Inc.

Can a public offering be used to stave off bankruptcy?

It is quite counter-intuitive but in this world we live in, a public offering can actually be a viable method to stave off bankruptcy. This is something that management of the over-the-counter and pink sheet stocks of yesteryear are well aware. In many cases, a failing private company may have been organized with good intentions and its management may have at one time been legitimate businessmen. However, when forced with a possible bankruptcy or a demise of some other nature, these good intentions are routinely dismissed in favor of businessmen retaining some form of legitimacy. In this case, specifically the case of CFMS and its July 1, 2015 IPO, the management of CFMS were likely considering bankruptcy should their IPO not succeed. Through March 31, 2015, CFMS had raised approximately $320 million and generated losses of approximately $282 million. CFMS had approximately $23 million in cash at March 31, 2015 and had approximately $14 million in cashflows used in operations for the three months ended March 31, 2015. Therefore, CFMS used approximately $4.67 million of cash in operations per month during the three months ended March 31, 2015. At that rate, if the IPO had not been successful, CFMS may have run out of cash by August 31, 2015 and could have been bankrupt today rather than being listed on the NASDAQ with a market value of just over $500 million.

Is there an inherent error rate in CFMS?

In our review of CFMS SEC filings, we noted that management has chosen not to disclose well known technological limitations associated with technology utilized by the CFMS platform. For example, it is a well-known fact that 3D printing involves an inherent error rate. Additionally, both CT scans and 3D printing, especially DMLS 3D printing, require human interaction. As a result, human error is also inherent in the CFMS manufacturing process.

Sales

Release

Risks

• 5 equities research analysts have issued 1 year price objectives for ConforMIS's shares. Their forecasts range from $2.50 to $4.00. On average, they expect ConforMIS's share price to reach $3.1250 in the next twelve months. This suggests that the stock has a possible downside of 4.4%. View Analyst Price Targets for ConforMIS.

See more on marketbeat.com

Ratings

Funding

Ownership

Business

Location